TrialEuropean journal of clinical pharmacology2012

Pharmacodynamics and pharmacokinetics of the novel PAR-1 antagonist vorapaxar (formerly SCH 530348) in healthy subjects.

Teddy Kosoglou et al.PubMed ↗Publisher ↗

No numbers read from the abstract.